Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Zhang, Xiaofang ^a   Ye, Lei ^a   Hu, Jiong ^a   Tang, Wei ^a   Liu, Ruixin ^a   Yang, Minglan ^a   Hong, Jie ^a   Wang, Weiqing ^a   Ning, Guang ^a,b   Gu, Weiqiong ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CD16 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 12; STAT4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7; PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL POLARITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DRUG RESPONSE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HYPERGLYCEMIA; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; SIGNAL TRANSDUCTION; TH1 CELL; TREATMENT DURATION; UPREGULATION; ACUTE DISEASE; BIOSYNTHESIS; BLOOD; CD8+ T LYMPHOCYTE; CHEMISTRY; CYTOLOGY; DNA MICROARRAY; FLOW CYTOMETRY; GENOMICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; PANCREAS ISLET BETA CELL; TIME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENOMICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INSULIN-SECRETING CELLS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDES; TIME FACTORS;

EID: 84863155487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031887     Document Type: Article

References (29)

1. American Diabetes Association (2004) Diagnosis and classification of diabetes. Diabetes Care 27 (suppl I): S5-S10.
2. Lehuen Agnès, Diana Julien, Zaccone Paola, Cooke Anne, (2010) Immune cell crosstalk in type 1 diabetes. Nature Reviews Immunology 10: 501-5133.
3. Notkins AL, Lernmark A, (2001) Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 108: 1247-1252.
4. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-98.
5. Chatenoud L, (2003) CD3-specific antibody-induced active tolerance: From bench to bedside. Nat. Rev. Immunol 3: 123-132.
6. Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, et al. (2007) Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297: 1568-1576.
7. Couri CE, Oliveira MC, Stracieri AB, Moraes DA, Pieroni F, et al. (2009) C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301: 1573-9.
8. American Diabetes Association (2007) Diagnosis and classification of diabetes mellitus. Diabetes Care 30 (Suppl 1): S42-S474.
9. Fuller TF, Ghazalpour A, Aten JE, Drake TA, Lusis AJ, et al. (2007) Weighted gene coexpression network analysis strategies applied to mouse weigh. Mamm Genome 18 (6-7): 463-72.
10. Wright GW, Simon RM, (2003) A random variance model for detection of differential gene expression in small microarray experiments. Bioinformatics 19 (18): 2448-2455.
11. Marmont AM, van Lint MT, Gualandi F, Bacigalupo A, (1997) Autologous marrow mstem cell transplantation for systemic lupus erythematosus of long duration. Lupus 6: 545-548.
12. Beard ME, Willis JA, Scott RS, Nesbit JW, (2002) Is type 1 diabetes transmissible by bone marrow allograft? Diabetes Care 25 (4): 799-800.
13. Atkinson MA, Leiter EH, (1999) The NOD mouse model of type 1 diabetes: as good as it gets? Nature Med 6: 601-604.
14. Wen Y, Ouyang J, Yang R, Chen J, Liu Y, et al. (2008) Reversal of new onset type 1 diabetes in mice by syngeneic bone marrow transplantation. Biochem. Biophys Res Commun 374: 282-287.
15. Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, et al. (2008) Autologous hematopoietic stem cell transplantation for type 1 diabetes. Ann N Y Acad Sci 2008 1150: 220-9.
16. Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, et al. (2004) C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function. Diabetes 53: 250-264.
17. Muraro PA, Douek DC, Packer A, Chung K, Guenaga FJ, et al. (2005) Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 201: 805-816.
18. Alexander T, Thiel A, Rosen O, Massenkeil G, Sattler A, et al. (2009) Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood 113: 214-223.
19. Reynier F, Pachot A, Paye M, Xu Q, Turrel-Davin F, et al. (2010) Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis. Genes Immun 11: 269-78.
20. Tsukamoto H, Nagafuji K, Horiuchi T, Mitoma H, Niiro H, et al. (2011) Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells. Rheumatology 50 (5): 944-52.
21. Suk K, Kim S, Kim YH, Kim KA, Chang I, et al. (2001) IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol 166: 4481-4489.
22. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, et al. (2004) Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430: 88-93.
23. Jeong H, Mason SP, Barabasi AL, Oltvai ZN, (2001) Lethality and centrality in protein networks. Nature 411: 41-42.
24. Erlich HA, Valdes AM, Julier C, Mirel D, Noble JA, et al. (2009) Evidence for association of the TCF7 locus with type I diabetes. Genes Immun Suppl 1: S54-59.
25. Zhou X, Yu S, Zhao DM, Harty JT, Badovinac VP, Xue HH, (2010) Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. Immunity 33: 229-240.
26. de Kleer I, Vastert B, Klein M, Teklenburg G, Arkesteijn G, et al. (2006) Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 107: 1696-1702.
27. Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, et al. (2008) Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 29: 720-733.
28. Martinvalet D, Dykxhoorn DM, Ferrini R, Lieberman J, (2008) Granzyme A cleaves a mitochondrial complex I protein to initiate caspase-independent cell death. Cell 133: 681-692.
29. Held W, MacDonald HR, Weissman IL, Hess MW, Mueller C, (1990) Immunology Genes encoding tumor necrosis factor a and granzyme A are expressed during development of autoimmune diabetes. Proc Natl Acad Sci 87: 2239-2243.